European Commission approved a control mechanism that can prevent large quantities of immunizers from being exported and impact the supply of vaccines to the EU
The government of Italy banned the export of 250 thousand doses of the vaccine from AstraZeneca against Covid-19 to the Australia, becoming the first country in the European Union to make some decision in that type. Italy transferred the decision to European Commission (EC) in the last week and Community Executive, who has the last word on the matter, was not against the decision decreed by Rome. Mario Draghi, new Italian Prime Minister, spoke with the EC representative, Ursula Von der Leyen, on Wednesday, 3, on how to accelerate the acceleration of vaccination against Covid-19. Brussels, headquarters of the European Commission, approved a mechanism for controlling the export of medicines.
The approval of the mechanism came after a controversy with AstraZeneca after the announcement that the company would supply less than half of the doses agreed with Brussels in the first quarter of 2021. The suspicion is that the pharmaceutical company would be selling the rest of the vaccine to the UK. The company rejected the innuendo. The measure requires companies to notify national authorities how many doses manufactured in their territory they intend to export to other countries, and the sale can only happen if the country in which the product is manufactured authorizes – the maximum period is 48 hours. Despite deciding how to proceed, countries have to consult the EC. Doses can be blocked if it is considered that the quantity exported could affect the supply of vaccines to the EU.
* With information from EFE